Table 1.
Prevalence of metabolic disorders associated with obesity.
| Variables | Baseline (%) | After therapy (%) | P value | |
|---|---|---|---|---|
| Metabolic syndrome factors (IDF classification) | Glucose | 13 | 5 | <0.001 |
| Insulin | 23 | 4 | <0.001 | |
| Triglyceride | 17 | 7 | <0.001 | |
| HDL-cholesterol | 42 | 31 | 0.30 | |
| Systolic blood pressure | 26 | 5 | <0.001 | |
| Diastolic blood pressure | 14 | 2 | <0.001 | |
| Waist circumference | 62 | 14 | <0.001 | |
|
| ||||
| MS NAFLD |
Metabolic syndrome | 30 | 2 | <0.001 |
| Nonalcoholic fatty liver disease | 33 | 10 | <0.001 | |
|
| ||||
| Others complications | HOMA-IR | 83 | 40 | <0.001 |
| Hyperleptinemia | 75 | 55 | <0.001 | |
| Asthma | 16 | 0 | <0.001 | |
| Binge eating | 6 | 2 | <0.001 | |
Statistical significance P ≤ 0.05; HOMA-IR: homeostasis model assessment insulin-index resistance; HLD: high-density lipoprotein; IDF: International Diabetes Federation; MS: metabolic syndrome; NAFLD: nonalcoholic fatty liver disease.